サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1279892

慢性疾患管理向け治療およびデバイス技術の世界市場規模調査＆予測、疾患別、治療別、デバイス別、地域別分析、2023-2030年

Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease by Therapy, by Device and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
慢性疾患管理向け治療およびデバイス技術の世界市場規模調査＆予測、疾患別、治療別、デバイス別、地域別分析、2023-2030年
出版日: 2023年05月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の慢性疾患管理向け治療およびデバイス技術市場は、2022年に約203億5,000万米ドルと評価され、予測期間2023-2030年には1.5%以上の健全な成長率で成長すると予測されています。

世界の慢性疾患管理向け治療およびデバイス技術市場は、糖尿病、心血管疾患、がん、呼吸器疾患などの慢性疾患の治療および管理に使用される製品およびサービスの市場と定義することができます。これには、慢性疾患に伴う症状や合併症を管理することで、患者の予後や生活の質を改善することを目的とした医薬品、医療機器、その他のヘルスケアテクノロジーが含まれます。世界の慢性疾患管理向け治療およびデバイス技術市場の促進要因は、慢性疾患の有病率の増加、老年人口の増加、医療費の増加です。さらに、革新的な治療法に対する需要の高まりと医療技術の進歩が、予測期間2023年から2030年にかけて、市場に有利な成長機会を生み出しています。

Global Burden of Disease」調査では、2020年に世界で17億人が少なくとも1つの慢性疾患を抱え、4億1500万人が複数の慢性疾患を抱えていると推定されています。慢性疾患の世界の負担は増加しており、糖尿病、心血管疾患、がん、呼吸器疾患などの疾患が、世界中で多くの人々に影響を与えています。このため、新しく効果的な治療法や管理戦略への需要が高まっています。例えば、2021年、国際糖尿病連合（IDF）は、成人の糖尿病の世界の有病率が2019年の9.3％から10.5％に上昇したことを報告しました。これは、世界中で4億6,300万人の成人が糖尿病と共存していると推定されることを表しています。同様に、米国がん協会によると、世界のがん負担は、2020年の推定1930万人の新規症例から、2040年までに年間2950万人に増加すると予測されています。これは、わずか20年で50％以上増加したことになります。しかし、慢性疾患管理向け治療およびデバイス技術の高コストが、2023年から2030年の予測期間を通じて市場の成長を阻害しています。

慢性疾患管理向け治療およびデバイス技術の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、慢性疾患管理向け治療およびデバイス技術の圧倒的な市場であり、世界市場のかなりのシェアを占めています。同地域の強固なヘルスケアインフラ、高い医療費、有利な償還政策が、市場成長を後押ししています。アジア太平洋地域は、慢性疾患管理向け治療およびデバイス技術市場において、今後数年間で最も急速に成長する地域です。市場成長を促進する要因としては、人口の増加、ヘルスケア支出の増加、慢性疾患の有病率の増加などが挙げられます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や市場情勢の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界市場・セグメント別市場推計・予測、2020年～2030年
    • 慢性疾患管理向け治療およびデバイス技術市場：地域別（2020-2030年
    • 慢性疾患管理向け治療およびデバイス技術市場：疾患別、2020-2030年
    • 慢性疾患管理向け治療およびデバイス技術市場：治療法別、2020年～2030年
    • 慢性疾患管理向け治療およびデバイス技術市場：デバイス別、2020年～2030年
  • 主要動向
  • 調査手法
  • 調査の前提条件

第2章 慢性疾患管理向け治療およびデバイス技術の世界市場定義とスコープ

  • 調査目的
  • 市場の定義とスコープ
    • 産業の進化
    • 本調査の対象範囲
  • 調査対象年
  • 通貨換算レート

第3章 慢性疾患管理向け治療およびデバイス技術の世界市場力学

  • 慢性疾患管理向け治療およびデバイス技術市場のインパクト分析（2020年～2030年）
    • 市場促進要因
      • 慢性疾患の有病率の増加
      • 老年人口の増加
      • ヘルスケア支出の増加
    • 市場の課題
      • 慢性疾患管理治療薬やデバイス技術の高コスト化
    • 市場機会
      • 革新的な治療法への需要の高まり
      • 医療技術の進歩

第4章 世界の慢性疾患管理向け治療およびデバイス技術市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースインパクト分析
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
    • 環境
    • 法律
  • トップ投資機会
  • 主要成功戦略
  • COVID-19影響度分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの提言と結論

第5章 慢性疾患管理向け治療およびデバイス技術の世界市場：疾患別

  • 市場スナップショット
  • 慢性疾患管理向け治療およびデバイス技術の世界市場：疾患別、実績、ポテンシャル分析
  • 慢性疾患管理向け治療およびデバイス技術の世界市場、疾患別推定・予測2020～2030年
  • 慢性疾患管理向け治療およびデバイス技術市場、サブセグメント別分析
    • 心血管疾患（CVD）
    • 糖尿病（Diabetes
    • がん
    • 慢性呼吸器疾患
    • 慢性腎臓病
    • 神経系疾患
    • その他（自己免疫疾患、消化器疾患、その他多数）

第6章 慢性疾患管理向け治療およびデバイス技術の世界市場：治療別

  • 市場スナップショット
  • 慢性疾患管理向け治療およびデバイス技術の世界市場：治療別、実績-潜在能力分析
  • 慢性疾患管理向け治療およびデバイス技術の世界市場、治療別推定・予測2020-2030年
  • 慢性疾患管理向け治療およびデバイス技術市場、サブセグメント分析
    • 薬物療法
    • リハビリテーション療法
    • 行動療法
    • その他（遺伝子治療、幹細胞治療、その他多数）

第7章 慢性疾患管理向け治療およびデバイス技術の世界市場：デバイス別

  • 市場スナップショット
  • 慢性疾患管理向け治療およびデバイス技術の世界市場：デバイス別、実績-潜在能力分析
  • 慢性疾患管理向け治療およびデバイス技術の世界市場、デバイス別推定・予測2020-2030年
  • 慢性疾患管理向け治療およびデバイス技術市場、サブセグメント別分析
    • 血糖値測定装置
    • 血圧モニター
    • 心臓モニター
    • 呼吸器治療器
    • 腎臓透析装置
    • 神経刺激装置
    • その他（インスリンポンプ、持続的グルコースモニタリング装置、その他多数）

第8章 慢性疾患管理向け治療およびデバイス技術の世界市場、地域分析

  • 上位の主要国
  • 上位新興国
  • 慢性疾患管理向け治療およびデバイス技術市場、地域別市場スナップショット
  • 北米
    • 米国
      • 疾患別推定・予測、2020-2030年
      • 治療法の推定・予測、2020-2030年
      • デバイス別の推定・予測、2020-2030年
    • カナダ
  • 欧州慢性疾患管理向け治療およびデバイス技術市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の慢性疾患管理向け治療およびデバイス技術市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの慢性疾患管理向け治療およびデバイス技術市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ地域
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • トップ市場戦略
  • 企業プロファイル
    • Medtronic plc
      • 主要情報
      • 概要
      • 財務情報（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Novo Nordisk A/S
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc
    • Johnson & Johnson Consumer Incd
    • Sanofi S.A.
    • Dexcom, Inc.
    • AstraZeneca plc
    • Becton, Dickinson and Company（BD）

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Chronic Disease Management Therapeutics and Device Technologies Market, report scope
  • TABLE 2. Global Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by Disease 2020-2030 (USD Billion)
  • TABLE 4. Global Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by Therapy 2020-2030 (USD Billion)
  • TABLE 5. Global Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by Device 2020-2030 (USD Billion)
  • TABLE 6. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Chronic Disease Management Therapeutics and Device Technologies Market
  • TABLE 71. List of primary sources, used in the study of global Chronic Disease Management Therapeutics and Device Technologies Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Chronic Disease Management Therapeutics and Device Technologies Market, research methodology
  • FIG 2. Global Chronic Disease Management Therapeutics and Device Technologies Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Chronic Disease Management Therapeutics and Device Technologies Market, key trends 2022
  • FIG 5. Global Chronic Disease Management Therapeutics and Device Technologies Market, growth prospects 2023-2030
  • FIG 6. Global Chronic Disease Management Therapeutics and Device Technologies Market, porters 5 force model
  • FIG 7. Global Chronic Disease Management Therapeutics and Device Technologies Market, pest analysis
  • FIG 8. Global Chronic Disease Management Therapeutics and Device Technologies Market, value chain analysis
  • FIG 9. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Chronic Disease Management Therapeutics and Device Technologies Market, regional snapshot 2020 & 2030
  • FIG 15. North America Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Chronic Disease Management Therapeutics and Device Technologies Market is valued at approximately USD 20.35 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.5% over the forecast period 2023-2030. The global chronic disease management therapeutics and device technologies market can be defined as the market for products and services that are used in the treatment and management of chronic diseases, such as diabetes, cardiovascular disease, cancer, respiratory disease, and others. This includes pharmaceuticals, medical devices, and other healthcare technologies that are designed to improve patient outcomes and quality of life by managing the symptoms and complications associated with chronic diseases. The driving factors for the Global Chronic Disease Management Therapeutics and Device Technologies Market are the growing prevalence of chronic diseases, growing geriatric population and rising healthcare expenditure. Moreover, increasing demand for innovative therapies and advances in medical technology is creating lucrative growth opportunities for the market over the forecast period 2023-2030.

The Global Burden of Disease study estimated that in 2020, 1.7 billion people worldwide had at least one chronic disease, and 415 million had multiple chronic diseases. The global burden of chronic diseases is increasing, with conditions such as diabetes, cardiovascular disease, cancer, and respiratory disease affecting a growing number of people worldwide. This is driving demand for new and effective treatments and management strategies. For instance, in 2021, the International Diabetes Federation (IDF) reported that the global prevalence of diabetes had risen to 10.5% among adults, up from 9.3% in 2019. This represents an estimated 463 million adults living with diabetes worldwide. Similarly, according to the American Cancer Society, the global cancer burden is expected to rise to 29.5 million new cases annually by 2040, up from an estimated 19.3 million new cases in 2020. This represents an increase of more than 50% in just 20 years. However, the high cost of Chronic Disease Management Therapeutics and Device Technologies stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Chronic Disease Management Therapeutics and Device Technologies Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is the dominating market for chronic disease management therapeutics and device technologies, accounting for a significant share of the global market. The region's strong healthcare infrastructure, high healthcare spending, and favorable reimbursement policies are driving the market growth. The Asia Pacific region is the fastest growing region in the chronic disease management therapeutics and device technologies market in the coming years. Factors driving market growth include the growing population, rising healthcare spending, and increasing prevalence of chronic diseases.

Major market players included in this report are:

  • Medtronic plc
  • Novo Nordisk A/S
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Johnson & Johnson Consumer Inc.
  • Sanofi S.A.
  • Dexcom, Inc.
  • AstraZeneca plc
  • Becton, Dickinson and Company (BD)

Recent Developments in the Market:

  • In September 2020, Medtronic launched its MiniMed 770G insulin pump system, which uses advanced algorithms to automatically adjust insulin delivery to help people with diabetes better manage their blood sugar levels.
  • In June 2020, Abbott received FDA clearance for its FreeStyle Libre 2 continuous glucose monitoring system, which allows people with diabetes to monitor their glucose levels without the need for fingerstick.

Global Chronic Disease Management Therapeutics and Device Technologies Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Disease, Therapy, Device, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Disease offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Disease:

  • Cardiovascular diseases (CVD)
  • Diabetes
  • Cancer
  • Chronic respiratory diseases
  • Chronic kidney diseases
  • Neurological disorders
  • Others (such as autoimmune diseases, gastrointestinal disorders, and many)

By Therapy:

  • Medications
  • Rehabilitation therapy
  • Behavioral therapy
  • Others (such as gene therapy, stem cell therapy, and many)

By Device:

  • Blood glucose monitoring devices
  • Blood pressure monitors
  • Cardiac monitors
  • Respiratory therapy devices
  • Kidney dialysis machines
  • Neurostimulation devices
  • Others (such as insulin pumps, continuous glucose monitoring devices, and many)

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Chronic Disease Management Therapeutics and Device Technologies Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Chronic Disease Management Therapeutics and Device Technologies Market, by Disease, 2020-2030 (USD Billion)
    • 1.2.3. Chronic Disease Management Therapeutics and Device Technologies Market, by Therapy, 2020-2030 (USD Billion)
    • 1.2.4. Chronic Disease Management Therapeutics and Device Technologies Market, by Device, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Chronic Disease Management Therapeutics and Device Technologies Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Chronic Disease Management Therapeutics and Device Technologies Market Dynamics

  • 3.1. Chronic Disease Management Therapeutics and Device Technologies Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of chronic diseases
      • 3.1.1.2. Growing Geriatric Population
      • 3.1.1.3. Rising healthcare expenditure
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Chronic Disease Management Therapeutics and Device Technologies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing demand for innovative therapies
      • 3.1.3.2. Advances in medical technology

Chapter 4. Global Chronic Disease Management Therapeutics and Device Technologies Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Chronic Disease Management Therapeutics and Device Technologies Market, by Disease

  • 5.1. Market Snapshot
  • 5.2. Global Chronic Disease Management Therapeutics and Device Technologies Market by Disease, Performance - Potential Analysis
  • 5.3. Global Chronic Disease Management Therapeutics and Device Technologies Market Estimates & Forecasts by Disease 2020-2030 (USD Billion)
  • 5.4. Chronic Disease Management Therapeutics and Device Technologies Market, Sub Segment Analysis
    • 5.4.1. Cardiovascular diseases (CVD)
    • 5.4.2. Diabetes
    • 5.4.3. Cancer
    • 5.4.4. Chronic respiratory diseases
    • 5.4.5. Chronic kidney diseases
    • 5.4.6. Neurological disorders
    • 5.4.7. Others (such as autoimmune diseases, gastrointestinal disorders, and many)

Chapter 6. Global Chronic Disease Management Therapeutics and Device Technologies Market, by Therapy

  • 6.1. Market Snapshot
  • 6.2. Global Chronic Disease Management Therapeutics and Device Technologies Market by Therapy, Performance - Potential Analysis
  • 6.3. Global Chronic Disease Management Therapeutics and Device Technologies Market Estimates & Forecasts by Therapy 2020-2030 (USD Billion)
  • 6.4. Chronic Disease Management Therapeutics and Device Technologies Market, Sub Segment Analysis
    • 6.4.1. Medications
    • 6.4.2. Rehabilitation therapy
    • 6.4.3. Behavioral therapy
    • 6.4.4. Others (such as gene therapy, stem cell therapy, and many)

Chapter 7. Global Chronic Disease Management Therapeutics and Device Technologies Market, by Device

  • 7.1. Market Snapshot
  • 7.2. Global Chronic Disease Management Therapeutics and Device Technologies Market by Device, Performance - Potential Analysis
  • 7.3. Global Chronic Disease Management Therapeutics and Device Technologies Market Estimates & Forecasts by Device 2020-2030 (USD Billion)
  • 7.4. Chronic Disease Management Therapeutics and Device Technologies Market, Sub Segment Analysis
    • 7.4.1. Blood glucose monitoring devices
    • 7.4.2. Blood pressure monitors
    • 7.4.3. Cardiac monitors
    • 7.4.4. Respiratory therapy devices
    • 7.4.5. Kidney dialysis machines
    • 7.4.6. Neurostimulation devices
    • 7.4.7. Others (such as insulin pumps, continuous glucose monitoring devices, and many)

Chapter 8. Global Chronic Disease Management Therapeutics and Device Technologies Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Chronic Disease Management Therapeutics and Device Technologies Market, Regional Market Snapshot
  • 8.4. North America Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.4.1. U.S. Chronic Disease Management Therapeutics and Device Technologies Market
      • 8.4.1.1. Disease breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Therapy breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Device breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Chronic Disease Management Therapeutics and Device Technologies Market
  • 8.5. Europe Chronic Disease Management Therapeutics and Device Technologies Market Snapshot
    • 8.5.1. U.K. Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.2. Germany Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.3. France Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.4. Spain Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.5. Italy Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.6. Rest of Europe Chronic Disease Management Therapeutics and Device Technologies Market
  • 8.6. Asia-Pacific Chronic Disease Management Therapeutics and Device Technologies Market Snapshot
    • 8.6.1. China Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.2. India Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.3. Japan Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.4. Australia Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.5. South Korea Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.6. Rest of Asia Pacific Chronic Disease Management Therapeutics and Device Technologies Market
  • 8.7. Latin America Chronic Disease Management Therapeutics and Device Technologies Market Snapshot
    • 8.7.1. Brazil Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.7.2. Mexico Chronic Disease Management Therapeutics and Device Technologies Market
  • 8.8. Middle East & Africa Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.8.1. Saudi Arabia Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.8.2. South Africa Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.8.3. Rest of Middle East & Africa Chronic Disease Management Therapeutics and Device Technologies Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Medtronic plc
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Novo Nordisk A/S
    • 9.3.3. Abbott Laboratories
    • 9.3.4. F. Hoffmann-La Roche Ltd
    • 9.3.5. GlaxoSmithKline plc
    • 9.3.6. Johnson & Johnson Consumer Incd
    • 9.3.7. Sanofi S.A.
    • 9.3.8. Dexcom, Inc.
    • 9.3.9. AstraZeneca plc
    • 9.3.10. Becton, Dickinson and Company (BD)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption